Lactobacillus delbrueckii bulgaricus (Lb-64)
Mechanism of Action +
### Carbohydrate Fermentation and Lactic Acid Production Lactobacillus delbrueckii subsp. bulgaricus is a Gram-positive, non-motile, non-spore-forming rod-shaped bacterium. It is an obligate homofermentative organism, meaning it utilizes the Embden-Meyerhof-Parnas (EMP) pathway (glycolysis) to metabolize hexose sugars—primarily lactose—almost exclusively into lactic acid. The enzyme beta-galactosidase hydrolyzes lactose into glucose and galactose. Glucose is then metabolized into pyruvate, which is subsequently reduced to lactic acid by lactate dehydrogenase. This massive production of lactic acid serves a dual purpose: it provides the tart flavor and textural changes necessary for dairy fermentation (like yogurt), and in the human gastrointestinal tract, it significantly lowers the luminal pH. This acidic microenvironment is hostile to many putrefactive and pathogenic bacteria, thereby exerting a strong antimicrobial effect through competitive exclusion and environmental modification.
### Lipid Metabolism and Triglyceride Modulation Recent clinical investigations, including a 2024 pilot trial, have highlighted the ability of L. bulgaricus to modulate systemic lipid profiles, particularly blood triglycerides (TGs). The biochemical mechanisms underlying this effect are multifaceted. First, L. bulgaricus exhibits Bile Salt Hydrolase (BSH) activity. BSH enzymes catalyze the deconjugation of glycine- and taurine-conjugated bile acids into free bile acids and amino acid residues. Deconjugated bile acids are less efficiently reabsorbed in the terminal ileum and are subsequently excreted in the feces. To maintain bile acid homeostasis, the liver must synthesize new bile acids from endogenous cholesterol, thereby upregulating hepatic LDL receptors and drawing cholesterol from the systemic circulation.
Furthermore, the modulation of the gut microbiome by L. bulgaricus alters the production of short-chain fatty acids (SCFAs), particularly propionate and butyrate. Propionate can travel via the portal vein to the liver, where it has been shown to inhibit hepatic cholesterol synthesis by downregulating the activity of HMG-CoA reductase. More specifically regarding triglycerides, L. bulgaricus supplementation has been shown to alter the composition of circulating lipoproteins. It reduces the triglyceride proportion within large VLDL (L-XXL sized fractions) and HDL (M and L fractions). This suggests an interference with hepatic VLDL assembly, potentially through the downregulation of microsomal triglyceride transfer protein (MTP) or by altering the availability of fatty acids for hepatic esterification.
### Immunomodulation and Gut Barrier Function The cell wall components of L. bulgaricus, including peptidoglycan and lipoteichoic acid, act as microbe-associated molecular patterns (MAMPs). These structures are recognized by pattern recognition receptors (PRRs), such as Toll-like receptor 2 (TLR2), located on the surface of intestinal epithelial cells and dendritic cells within the gut-associated lymphoid tissue (GALT). Engagement of TLR2 initiates a signaling cascade involving MyD88 and NF-κB, leading to the secretion of immunomodulatory cytokines. L. bulgaricus tends to promote a regulatory immune phenotype, stimulating the production of Interleukin-10 (IL-10) while dampening pro-inflammatory cytokines like TNF-alpha and IL-6.
Additionally, L. bulgaricus contributes to the fortification of the intestinal epithelial barrier. It upregulates the expression of tight junction proteins, such as Zonula Occludens-1 (ZO-1) and occludin. By tightening the paracellular spaces between enterocytes, L. bulgaricus reduces intestinal permeability. This prevents the translocation of lipopolysaccharides (LPS) from Gram-negative gut bacteria into the systemic circulation, a condition known as metabolic endotoxemia. Since metabolic endotoxemia is a known driver of systemic low-grade inflammation and subsequent insulin resistance and dyslipidemia, the barrier-enhancing effects of L. bulgaricus indirectly support its metabolic and lipid-lowering benefits.
What are the benefits of Lactobacillus delbrueckii bulgaricus? +
Which Lactobacillus is best for BV? +
Is L bulgaricus good or bad for you? +
Who should not take Lactobacillus? +
What drugs should not be taken with probiotics? +
Does Lactobacillus interact with anything? +
Can Lactobacillus bulgaricus cause side effects? +
Does L. bulgaricus help with weight loss? +
How does it affect triglycerides? +
What is the difference between L. delbrueckii and L. bulgaricus? +
Is it safe during pregnancy? +
Can children take L. bulgaricus? +
Why is it used in yogurt? +
What is the recommended dose? +
Should I take it with food? +
How long does it take to work? +
Does it survive stomach acid? +
Can it cure acne or asthma? +
Everything About Lactobacillus delbrueckii bulgaricus (Lb-64) Article
## The Probiotic Powerhouse: Lactobacillus delbrueckii bulgaricus
When we think of probiotics, we often picture the standard strains found in daily supplements—*Lactobacillus acidophilus* or *Bifidobacterium bifidum*. However, *Lactobacillus delbrueckii subsp. bulgaricus* (often simply referred to as *L. bulgaricus*) holds a unique and foundational place in human nutrition. Discovered over a century ago by Bulgarian physician Stamen Grigorov, this specific strain of bacteria is the biological engine behind the fermentation of yogurt.
While its historical claim to fame is culinary, modern clinical sports nutrition and biochemistry are uncovering a new layer of utility for *L. bulgaricus*. Beyond simply aiding in digestion and lactose breakdown, emerging research suggests that specific strains, such as Lb-64, possess the ability to modulate systemic metabolism, specifically targeting blood lipids and triglycerides.
## Historical Context and Taxonomy
To understand *L. bulgaricus*, we must first look at its taxonomy. In April 2020, the massive *Lactobacillus* genus underwent a significant reclassification, split into 25 different genera to better reflect the genetic diversity of these bacteria. However, *Lactobacillus delbrueckii* retained its original namesake. What was once considered a standalone species (*Lactobacillus bulgaricus*) is now officially classified as a subspecies: *Lactobacillus delbrueckii subsp. bulgaricus*.
This bacterium is an obligate homofermenter. In simple terms, this means its primary metabolic function is to consume sugars (like lactose) and convert them almost entirely into lactic acid. This massive output of lactic acid is what gives yogurt its tart flavor and thick texture, but more importantly, it is the primary mechanism by which this bacterium protects the human gut.
## Core Mechanisms of Action
### Lactic Acid Production and Competitive Exclusion The human gastrointestinal tract is a highly competitive ecosystem. Pathogenic bacteria, yeasts, and putrefactive organisms are constantly vying for resources and attachment sites on the intestinal wall. *L. bulgaricus* acts as a biological terraformer. By producing large quantities of lactic acid, it significantly lowers the luminal pH of the gut. Most pathogenic bacteria cannot survive in this highly acidic microenvironment. This process, known as competitive exclusion, allows beneficial flora to thrive while suppressing harmful invaders.
### The Gut-Heart Axis: Lipid Metabolism The most exciting modern application for *L. bulgaricus* lies in its interaction with lipid metabolism. Probiotics can influence blood cholesterol and triglycerides through several pathways, primarily involving Bile Salt Hydrolase (BSH) activity.
The liver produces bile acids from cholesterol, which are secreted into the gut to help digest fats. Normally, these bile acids are reabsorbed and recycled. *L. bulgaricus* produces BSH enzymes that deconjugate these bile acids, making them less likely to be reabsorbed and more likely to be excreted in the feces. To replace the lost bile acids, the liver must pull cholesterol from the bloodstream, thereby lowering systemic lipid levels. Furthermore, the short-chain fatty acids (SCFAs) produced by a healthy microbiome can travel to the liver and directly inhibit the enzymes responsible for synthesizing new cholesterol and triglycerides.
## Clinical Evidence: What the Science Says
### Blood Lipids and Triglycerides The most compelling modern evidence for *L. bulgaricus* comes from a 2024 randomized pilot trial published in the journal *Metabolites* (Chu et al.). The researchers aimed to evaluate the efficacy of *L. bulgaricus* in managing body weight and blood lipids in overweight individuals.
Thirty-six participants were given either a placebo or a relatively modest dose of *L. bulgaricus* (1 × 10^8 CFU) daily for 12 weeks. The results were highly specific: while the probiotic did not cause weight loss, it resulted in a notable and significant decrease in blood triglyceride (TG) levels. Furthermore, the researchers noted a lowering of the TG proportion in the composition of large VLDL (very-low-density lipoprotein) and HDL (high-density lipoprotein) particles.
This is a critical finding for clinical nutrition. High triglycerides are a hallmark of metabolic syndrome and insulin resistance. By modulating how triglycerides are packaged and transported in the blood, *L. bulgaricus* demonstrates potential as a targeted supplement for cardiovascular and metabolic health, independent of weight loss.
### Weight Management: The Null Hypothesis It is equally important to highlight what *L. bulgaricus* did *not* do in the 2024 trial. The supplementation did not affect body weight, body fat percentage, or Body Mass Index (BMI).
The supplement industry frequently markets probiotics as "weight loss miracles" or "belly fat burners." The clinical data for *L. bulgaricus* directly refutes this marketing hyperbole. While optimizing the gut microbiome is essential for overall health and may indirectly support a healthy metabolism, taking *L. bulgaricus* alone will not cause spontaneous fat loss without a caloric deficit.
### General Digestive Health and Immunity According to authoritative sources like WebMD, *L. delbrueckii* is commonly used by consumers for conditions ranging from acne and hay fever to asthma and diarrhea. However, it is important to note that large-scale, definitive clinical evidence for these specific conditions remains insufficient.
What is well-established is its safety and its role in general digestive maintenance. Because it produces the enzyme beta-galactosidase, *L. bulgaricus* is highly effective at breaking down lactose, making it a valuable tool for individuals with lactose intolerance.
## Optimal Dosing and Delivery
When supplementing with *L. bulgaricus*, the clinical standard is measured in Colony Forming Units (CFU), which indicates the number of live, viable bacteria. The 2024 MDPI trial utilized a dose of 100 million CFU (1 × 10^8 CFU) daily. Many commercial probiotic blends will dose much higher, ranging from 1 billion to 10 billion CFU.
**Label Literacy:** When purchasing a probiotic, ignore products that list their probiotic content in milligrams (mg). Bacteria must be alive to be effective, and weight (mg) does not guarantee viability. Look for products that guarantee their CFU count through the *expiration date*, not just at the time of manufacture.
## Safety Profile and Contraindications
*Lactobacillus delbrueckii bulgaricus* is generally recognized as safe (GRAS) and is consumed globally in fermented dairy products. However, there are specific populations that must exercise caution:
1. **Immunocompromised Individuals:** People with severely weakened immune systems (due to HIV/AIDS, chemotherapy, or immunosuppressant drugs) should avoid probiotics unless directed by a doctor. Introducing live bacteria into a compromised system carries a rare but severe risk of bacteremia (blood infections). 2. **Damaged Heart Valves:** According to WebMD, probiotic preparations can, in extremely rare cases, cause an infection in the inner lining of the heart chambers and valves (endocarditis). Individuals with damaged heart valves should discontinue probiotics before dental or surgical procedures. 3. **Antibiotic Interactions:** Antibiotics do not discriminate between "good" and "bad" bacteria. Taking a probiotic simultaneously with an antibiotic will render the supplement useless. If you must take both, space the doses apart by at least 2 to 4 hours.
## Conclusion
*Lactobacillus delbrueckii bulgaricus* is far more than just a yogurt starter. As clinical research evolves, its role as a modulator of systemic lipid metabolism and blood triglycerides is becoming clearer. While it won't magically melt away body fat, it stands as a scientifically validated tool for supporting cardiovascular health, optimizing the gut microbiome, and maintaining robust digestive function.